National Academies Press: OpenBook

The Children's Vaccine Initiative: Achieving the Vision (1993)

Chapter: Appendix I: Working Group Participants

« Previous: Appendix H: Historical Record of Vaccine Product License Holders in the United States
Suggested Citation:"Appendix I: Working Group Participants." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
×

I
Working Group Participants June 11–13, 1992

Claire Broome, M.D.

Associate Director for Science

Centers for Disease Control and Prevention

Atlanta, GA

Douglas L. Cocks, Ph.D.

Manager, Corporate Affairs

Eli Lilly

Indianapolis, IN

Ronald Ellis, Ph.D.

Executive Director

Virus and Cell Biology

Merck & Co., Inc.

West Point, PA

Peter Evans

World Health Organization

Geneva, Switzerland

Bernard Fritzell, Ph.D.

Director of Clinical Research

Connaught Laboratories, Inc.

Swiftwater, PA

Lance Gordon, Ph.D.

President and CEO

ORAVAX

Cambridge, MA

Carolyn Hardegree, M.D.

Director, Office of Biologics Research

U.S. Food & Drug Administration

Bethesda, MD

Akira Homma, M.D.

Regional Advisor in Biologics

Pan American Health Organization

Washington, DC

Suggested Citation:"Appendix I: Working Group Participants." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
×

Pamela Johnson, Ph.D.

Chief, Applied Research Division

Office of Health

U.S. Agency for International Development

Washington, D.C.

Thomas D. Kiley, J.D.

Attorney

Hillsborough, CA

Pierre Lemoine

Chief, National Laboratory for Control of Vaccines

Ministry of Public Health

Brussels, Belgium

David Lohr

Vice President, Business Development

Medisorb Technologies International, Ltd.

Cincinnati, OH

Richard Mahoney, Ph.D.

Vice President and Director

Technology Promotion

Program for Appropriate Technology in Health

Seattle, WA

Harry M. Meyer, Jr., M.D.

President, Medical Research Division

American Cyanamid Co.

Pearl River, NY

David Mowery, Ph.D.

Associate Professor

University of California School of Business

Berkeley, CA

William Packer, C.P.A.

President

Virus Research Institute

Cambridge, MA

Timothy D. Proctor, J.D.

Associate General Counsel

Merck & Co., Inc.

Rahway, NJ

Philip K. Russell, M.D.

Professor, Division of International Health

John Hopkins School of Hygiene and Public Health

Baltimore, MD

Jerald C. Sadoff, M.D.

Director

Division of Communicable Diseases and Immunology

Walter Reed Army Institute for Research

Washington, DC

Jay P. Sanford, M.D.

Dean Emeritus

Uniformed Services University of the Health Sciences

Dallas, TX

Donald Shepard, Ph.D.

Professor

Institute for Health Policy

Brandeis University

Waltham, MA

Dale Spriggs, Ph.D.1

National Institute of Allergy and Infectious Diseases

Bethesda, Maryland

Suggested Citation:"Appendix I: Working Group Participants." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
×

Ann Wion, J.D.

Associate Chief Counsel for Drugs and Biologics

U.S. Food & Drug Administration

Bethesda, MD

WORKING GROUP PARTICIPANTS June 21–23, 1992

Frank Cano, Ph.D.2

Vice-President

Lederle-Praxis Biologicals

Pearl River, NY

Mary Lou Clements, M.D.

Professor and Head

Division of Vaccine Sciences

Johns Hopkins School of Hygiene and Public Health

Baltimore, MD

George Curlin, M.D.

Deputy Director

Division of Microbiology and Infectious Diseases

National Institute for Allergy and Infectious Diseases

Bethesda, MD

Ciro de Quadros, M.D.

Regional Advisor

Expanded Program on Immunization

Pan American Health Organization

Washington, DC

Michael Epstein, J.D.

Partner

Weil, Gotshal & Manges

New York, NY

Elaine Esber, M.D.

Associate Director

Center for Biologics Evaluation and Research

U.S. Food & Drug Administration

Bethesda, MD

Ronald W. Hansen, Ph.D.

Associate Dean for Academic Affairs

William E. Simon Graduate School of Business

University of Rochester

Rochester, NY

Kerri-Ann Jones, Ph.D.

Chief, Human Resources

Development, Energy and Private Sector

U.S. Agency for International Development

Washington, DC

David T. Karzon, M.D.

Professor

Vanderbilt University

Suggested Citation:"Appendix I: Working Group Participants." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
×

School of Medicine

Nashville, TN

Scott Koenig

MedImmune, Inc.

Gaithersburg, MD

David S. Krause, M.D.

Director, Clinical Research, Development and Medical Affairs

SmithKline Beecham

King of Prussia, PA

Wendy K. Mariner, J.D.

Professor of Health Law

Boston University

School of Public Health

Boston, MA

Douglas Reynolds

Vice President of Marketing

Connaught Laboratories, Inc.

Swiftwater, PA

Bryan Roberts, Ph.D.

Research Director

Virus Research Institute

Cambridge, MA

Amy Scott

Consumer Safety Officer

U.S. Food & Drug Administration

Bethesda, MD

Jane Scott, Ph.D.

Senior Director, Vaccine Development

Lederle-Praxis Biologicals

Pearl River, NY

Seung-il Shin, Ph.D.3

Eugene Technologies International, Inc.,

Ramsey, NJ

George Siber, M.D.

Director, Biologic Laboratories

Massachusetts Department of Public Health

Jamaica Plain, MA

Jane E. Sisk, Ph.D.

Professor

Columbia University School of Public Health

New York, NY

Thomas Stagnaro

President and CEO

UNIVAX Biologics

Rockville, MD

Richard I. Walker, Ph.D.

Science Advisor

National Vaccine Program

National Institutes of Health

Rockville, MD

Michael White, M.D.

Medical Officer

Applied Research Division

Office of Health

U.S. Agency for International Development

Washington, D.C.

Douglas Williams

Vice President, Marketing

Connaught Laboratories, Inc.

Swiftwater, PA

Suggested Citation:"Appendix I: Working Group Participants." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
×

James F. Young, Ph.D.

Vice President, Research & Development

MedImmune, Inc.

Gaithersburg, MD

NOTES

1.  

Dr. Spriggs is now with Virus Research Institute in Cambridge, MA.

2.  

Dr. Cano is now President, Aviron, Belmont, Ca.

3.  

Dr. Shin is now with the United Nations Development Program, New York, NY.

Suggested Citation:"Appendix I: Working Group Participants." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
×
Page 205
Suggested Citation:"Appendix I: Working Group Participants." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
×
Page 206
Suggested Citation:"Appendix I: Working Group Participants." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
×
Page 207
Suggested Citation:"Appendix I: Working Group Participants." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
×
Page 208
Suggested Citation:"Appendix I: Working Group Participants." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
×
Page 209
Next: Appendix J: Committee and Staff Biographies »
The Children's Vaccine Initiative: Achieving the Vision Get This Book
×
Buy Paperback | $50.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The Children's Vaccine Initiative is an international endeavor to ensure that children throughout the world are immunized. This book notes that one of the best opportunities to address the growing problem of immunization in the United States and to improve the health of children in developing countries lies in marshaling the vaccine development and production efforts in the United States and abroad. The book contains information on the nature and status of vaccine development and production efforts in the United States and abroad, and it recommends ways to enhance participation in the International Children's Vaccine Initiative.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!